Home / Funds / Voleon Capital Management LP
Voleon Capital Management LP
The short positions this fund discloses today, across every market.
| Issuer | Market | % of capital | Since | Filing |
|---|---|---|---|---|
| B&M European Value Retail S.A. | Germany | 0.79% | April 20, 2026 | |
| Oryzon Genomics, S.A. | Spain | 0.60% | October 5, 2026 | |
| Tubacex, S.A. | Spain | 0.60% | October 30, 2026 | |
| Genuit Group plc | Germany | 0.54% | October 20, 2026 | |
| Atos Group | France | 0.50% | October 21, 2026 | |
| Mips AB | Sweden | 0.50% | October 21, 2026 |
Get the moves on Voleon Capital Management LP by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Issuer | Market | % of capital | End of publication | Filing |
|---|---|---|---|---|---|
| April 6, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.57% | ||
| April 6, 2021 | 4D Pharma PLC | United Kingdom | 0.52% | ||
| April 6, 2021 | Maire SPA | Italy | 0.49% | ||
| April 6, 2021 | Digital Bros SPA | Italy | 0.45% | ||
| April 1, 2021 | Eurotech SPA | Italy | 1.55% | ||
| April 1, 2021 | Digital Bros SPA | Italy | 0.58% | ||
| April 1, 2021 | 4D Pharma PLC | United Kingdom | 0.44% | ||
| March 31, 2021 | Cell Impact AB (publ) | Sweden | 1.06% | ||
| March 31, 2021 | Duro Felguera, S.A. | Spain | 0.74% | ||
| March 31, 2021 | Digital Bros SPA | Italy | 0.65% | ||
| March 31, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.60% | ||
| March 31, 2021 | Metabolic Explorer | France | 0.52% | April 15, 2021 | |
| March 30, 2021 | Digital Bros SPA | Italy | 0.71% | ||
| March 30, 2021 | Duro Felguera, S.A. | Spain | 0.64% | ||
| March 30, 2021 | 4D Pharma PLC | United Kingdom | 0.58% | ||
| March 30, 2021 | Oncopeptides AB | Sweden | 0.58% | ||
| March 30, 2021 | Maire SPA | Italy | 0.50% | ||
| March 29, 2021 | Eurotech SPA | Italy | 1.66% | ||
| March 29, 2021 | Digital Bros SPA | Italy | 0.81% | ||
| March 29, 2021 | Oncopeptides AB | Sweden | 0.66% | ||
| March 26, 2021 | 4D Pharma PLC | United Kingdom | 0.69% | ||
| March 25, 2021 | Biophytis | France | 1.09% | June 18, 2021 | |
| March 25, 2021 | Cell Impact AB (publ) | Sweden | 0.94% | ||
| March 25, 2021 | Immunovia AB (publ) | Sweden | 0.60% | ||
| March 24, 2021 | Biophytis | France | 1.10% | June 18, 2021 | |
| March 24, 2021 | Nicox SA | France | 0.70% | May 19, 2021 | |
| March 24, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.50% | ||
| March 23, 2021 | Metro Bank PLC | United Kingdom | 0.69% | ||
| March 23, 2021 | Duro Felguera, S.A. | Spain | 0.52% | ||
| March 22, 2021 | Navya | France | 1.41% | August 3, 2021 | AMF |
| March 22, 2021 | 4D Pharma PLC | United Kingdom | 0.75% | ||
| March 19, 2021 | Eurotech SPA | Italy | 1.53% | ||
| March 19, 2021 | 4D Pharma PLC | United Kingdom | 0.95% | ||
| March 19, 2021 | Digital Bros SPA | Italy | 0.91% | ||
| March 18, 2021 | Eurotech SPA | Italy | 1.44% | ||
| March 18, 2021 | 4D Pharma PLC | United Kingdom | 0.84% | ||
| March 18, 2021 | Metro Bank PLC | United Kingdom | 0.76% | ||
| March 18, 2021 | Oncopeptides AB | Sweden | 0.70% | ||
| March 17, 2021 | Digital Bros SPA | Italy | 0.85% | ||
| March 17, 2021 | 4D Pharma PLC | United Kingdom | 0.76% | ||
| March 17, 2021 | Nicox SA | France | 0.60% | May 19, 2021 | |
| March 17, 2021 | Strategic Partners A/S | Denmark | 0.49% | March 17, 2021 | |
| March 16, 2021 | Navya | France | 1.31% | August 3, 2021 | AMF |
| March 16, 2021 | Digital Bros SPA | Italy | 0.76% | ||
| March 16, 2021 | Amoeba | France | 0.47% | March 18, 2021 | AMF |
| March 15, 2021 | Eurotech SPA | Italy | 1.30% | ||
| March 15, 2021 | Quantum Genomics | France | 1.14% | June 14, 2021 | |
| March 15, 2021 | Erytech Pharma | France | 0.49% | March 23, 2021 | |
| March 15, 2021 | Phaxiam Therapeutics | France | 0.49% | March 23, 2021 | |
| March 12, 2021 | Solocal Group | France | 0.61% | April 15, 2021 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 6,010 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
The funds short on the same companies
- Capital Fund Management 1 company in common
- Capital Fund Management SA 1 company in common
- CenterBook Partners LP 1 company in common
- Citadel Advisors LLC 1 company in common
- Connor Clark & Lunn Investment Management Ltd. 1 company in common
- D E Shaw Co LP 1 company in common
- GSA Capital Partners LLP 1 company in common
- JPMorgan Asset Management (UK) Ltd 1 company in common
- Marshall Wace LLP 1 company in common
- PDT Partners, LLC 1 company in common
- Squarepoint Ops LLC 1 company in common
- Systematica Investments Limited 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Voleon Capital Management LP, data as at October 30, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=66